Patents by Inventor Albert Mekking

Albert Mekking has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Erythropoietin solution formulation
    Patent number: 7468351
    Abstract: A stable pharmaceutical formulation of erythropoietin is disclosed which contains tris-(hydrox-ymethyl)-aminomethane as stabilizer, whereby the formulation does not contain amino acids or human serumalbumin.
    Type: Grant
    Filed: December 1, 2004
    Date of Patent: December 23, 2008
    Assignee: Bioggnerix AG
    Inventors: Stefan Arnold, Okke Franssen, Albert Mekking
  • Erythropoietin solution formulation
    Publication number: 20070128231
    Abstract: A stable pharmaceutical formulation of erythropoietin is disclosed which contains tris-(hydnox-ymethyl)-aminomethane as stabilizer, whereby the formulation does not contain amino acids or human serumalbumin.
    Type: Application
    Filed: December 1, 2004
    Publication date: June 7, 2007
    Applicant: BIOGENERIX AG
    Inventors: Stefan Arnold, Okke Franssen, Albert Mekking
  • Parathyroid hormone formulation
    Patent number: 5496801
    Abstract: Described herein are preparations containing parathyroid hormone that has been stablized with an excipient and buffering agent. Preferred preparations incorporate human PTH(1-84), mannitol as excipient and citrate as buffering agent, and are incorporated in vials as a freeze-dried powder for reconstitution to treat osteoporosis.
    Type: Grant
    Filed: December 23, 1993
    Date of Patent: March 5, 1996
    Assignee: Allelix BioPharmaceuticals Inc.
    Inventors: Josephus J. M. Holthuis, Albert Mekking, Alwinus A. Voetman